Pfizer

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Pfizer and other ETFs, options, and stocks.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
79,000
Employees79,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
79,000
Employees79,000

PFE Key Statistics

Market cap
291.11B
Market cap291.11B
Price-Earnings ratio
9.80
Price-Earnings ratio9.80
Dividend yield
3.14
Dividend yield3.14
Average volume
18.31M
Average volume18.31M
High today
$51.32
High today$51.32
Low today
$50.48
Low today$50.48
Open price
$50.66
Open price$50.66
Volume
16.88M
Volume16.88M
52 Week high
$61.71
52 Week high$61.71
52 Week low
$41.45
52 Week low$41.45

PFE News

Yahoo Finance 2d
UPDATE 1-Pfizer to invest more than $2.5 bln to expand European manufacturing - Yahoo Finance

* Belgian factory makes COVID-19 vaccines * Investment at a tough time for Europe amid energy crisis * Aims for as many as 19 new medicines over 1-1/2 year...

UPDATE 1-Pfizer to invest more than $2.5 bln to expand European manufacturing - Yahoo Finance
Simply Wall St 2d
Shareholders may not want to ignore the US$8.2m worth sales made by Pfizer Inc. insiders this past year

While Pfizer Inc. (NYSE:PFE) shareholders have had a good week with the stock up 4.6%, they shouldn't let their guards down. Even though stock prices were relat...

Shareholders may not want to ignore the US$8.2m worth sales made by Pfizer Inc. insiders this past year
Investor's Business Daily 3d
Will A Pfizer-Partnered Vaccine Help Valneva Stock Buck Its Recent Downtrend?

Valneva (VALN) stock rocketed Thursday after the company said volunteers who received its Pfizer (PFE)-partnered Lyme disease vaccine still had antibodies after...

Will A Pfizer-Partnered Vaccine Help Valneva Stock Buck Its Recent Downtrend?

Analyst ratings

52%

of 23 ratings
Buy
47.8%
Hold
52.2%
Sell
0%

PFE Earnings

$0.00
$0.68
$1.36
$2.04
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 7, Pre-Market
ActualExpected Feb 7, Pre-Market

More PFE News

Yahoo Finance 3d
Pfizer Invites Public to Register for Webcast of Pfizer Near-Term Launches + High-Value Pipeline Day - Yahoo Finance

NEW YORK, December 01, 2022--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to access a live video webcast of its Near-Term L...

Pfizer Invites Public to Register for Webcast of Pfizer Near-Term Launches + High-Value Pipeline Day - Yahoo Finance
Yahoo Finance 3d
UPDATE 2-Pfizer to invest over $1.26 billion in Irish jobs boost - Yahoo Finance

(Adds background) DUBLIN, Dec 1 (Reuters) - Pfizer Inc plans to invest more than 1.2 billion euros ($1.26 billion) to expand manufacturing at its plant in Dubl...

UPDATE 2-Pfizer to invest over $1.26 billion in Irish jobs boost - Yahoo Finance
Reuters 3d
UPDATE 1-Pfizer to invest over $1.26 billion in Dublin manufacturing site

(Adds details on facility, expansion plans) Dec 1 (Reuters) - Pfizer Inc said on Thursday it plans to invest more than 1.2 billion euros ($1.26 billion) to exp...

UPDATE 1-Pfizer to invest over $1.26 billion in Dublin manufacturing site
Yahoo Finance 3d
Global Hormone Replacement Therapy Market is expected to reach US$ 25.09 Billion by 2027 - Yahoo Finance

NEW YORK, Dec. 1, 2022 /PRNewswire/ -- Hormone Replacement Therapy Market, Global Forecast 2023-2027, Industry Trends, Growth, Impact of Inflation, Opportunity...

Global Hormone Replacement Therapy Market is expected to reach US$ 25.09 Billion by 2027 - Yahoo Finance
Yahoo Finance 3d
UPDATE 2-Roivant, Pfizer launch unit to develop inflammatory disease drug - Yahoo Finance

(Rewrites throughout, adds background, updates shares) Dec 1 (Reuters) - Roivant Sciences and Pfizer Inc on Thursday said they were forming a unit to advance t...

UPDATE 2-Roivant, Pfizer launch unit to develop inflammatory disease drug - Yahoo Finance
MarketWatch 3d
Roivant, Pfizer form company to develop ulcerative colitis treatment

Roivant Sciences ROIV, +4.89% and Pfizer Inc. PFE, +1.29% said Thursday that they created a new company focused on developing and commercializing an ulcerative...

Roivant, Pfizer form company to develop ulcerative colitis treatment
Reuters 3d
Roivant, Pfizer create unit for inflammatory disease drug - Reuters

Dec 1 (Reuters) - Roivant Sciences (ROIV.O) and Pfizer Inc (PFE.N) on Thursday announced the creation of a new unit to develop RVT-3101, the drugm...

Roivant, Pfizer create unit for inflammatory disease drug - Reuters
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.